mda-mb-468 glutathione content Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Frontiers | Formononetin triggers ferroptosis
Frontiers Formononetin triggers ferroptosis in triple negative breast cancer cells by regulating the mTORC1 SREBP1 SCD1 pathway MDA MB 468 Cell Line an overview ScienceDirect Topics Using a novel panel of drug resistant triple negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers ScienceDirect MDA MB 468 (DMEM) Cell Complete Medium Dual phenotype of MDA MB 468 cancer cells reveals mutual regulation of tensin3 and adhesion plasticity bioRxiv Gankyrin inhibits ferroptosis through the p53 SLC7A11 GPX4 axis in triple negative breast cancer cells Scientific Reports
Pay in 4 interest-free payments of $5.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




